Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 9, 2002, Pages 822-828

  Rodriguez, Carmen ^a   Calle, Eugenia E ^a   Fakhrabadi Shokoohi, Dorna ^a   Jacobs, Eric J ^a   Thun, Michael J ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OBESITY; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ADULT; AGED; BODY HEIGHT; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; OBESITY; OVARIAN NEOPLASMS; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 0036716824     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hormonal etiology of epithelial ovarian cancer, with a hypothesis considering the role of androgens and progesterone
2. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
3. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis
4. Body weight: Estimation of risk for breast and endometrial cancers
5. "Incessant ovulation" and ovarian cancer
6. An epidemiologic study of epithelial carcinoma of the ovary
7. Coffee and ovarian cancer
8. Case control study of high-risk factors in ovarian carcinomas
9. A case-control study of dietary and nondietary factors in ovarian cancer
10. A case-control study of epithelial ovarian cancer
11. Ovarian cancer and dietary habits
12. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer
13. Ovarian cancer risk and history of selected medical conditions linked with female hormones
14. Comparative case-referent study on risk factors among hormone-related female cancers in Japan
15. Association of obesity and ovarian cancer in a case-control study
16. Dietary factors and epithelial ovarian cancer
17. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study
18. Anthropometric and other risk factors for ovarian cancer in a case-control study
19. Ovarian cancer incidence and case-control study
20. Dietary animal fat in relation to ovarian cancer risk
21. Nutrient intake and ovarian cancer
22. Prospective study of recreational physical activity and ovarian cancer
23. Variations in mortality by weight among 750,000 men and women
24. Obesity and cancer risk: A Danish record-linkage study
25. Physical Activity, waist-to-hip ratio, and other risk factors for ovarian cancer: A follow-up study of older women
26. Menopausal hormone replacement therapy and risk of ovarian cancer
27. The epidemiology of serum sex hormones in postmenopausal women
28. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women
29. Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status
30. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
31. The reduction in risk of ovarian cancer associated with oral-contraceptive use
32. The epidemiology of ovarian cancer in Greece: A case-control study
33. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women
34. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants
35. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells
36. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52.705 women with breast cancer and 108,411 women without breast cancer
37. Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women
38. Serum gonadotropins and steroid hormones and the development of ovarian cancer
39. Metabolic implications of body fat distribution
40. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
41. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
42. Post-load plasma glucose and cancer mortality in middle aged men and women. 12 Year follow-up findings of the Chicago Heart Association Detection Project Industry
43. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
44. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
45. Effects of caloric restriction on insulin-like growth factor-I (IGF-1) and IGF-binding proteins in children and adults
46. Indices of relative weight and obesity
47. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population
48. Prognostic factors in early-onset epithelial ovarian cancer: A population-based study
49. The disease burden associated with overweight and obesity
50. The spread of the obesity epidemic in the United States, 1991-1998